-
Atalanta, now Arexera Therapeutics, reports pipeline update - BioWorld
... Huntington's disease franchise designed to address complementary drivers of disease onset and progression, supported by its divalent siRNA (di ...Read more
-
Brown scholar to play key role in federally funded project to prevent neurodegenerative disease
“Diseases like Alzheimer's disease, Huntington's disease, amyotrophic lateral sclerosis and Parkinson's disease involve proteins that misfold or ...Read more
-
Inside the Striatum: Why Neuronal Subtypes Hold the Key to Action and - Bioengineer.org
In parallel, Thabault and Galvan review the contribution of parvalbumin interneurons to striatal dysfunction in Huntington's disease and autism ...Read more
-
Medicare open enrollment 2027: What Michigan residents need to know - MLive.com
Austedo and Austedo XR for Huntington's disease and tardive dyskinesia;; Breo Ellipta for asthma and chronic obstructive pulmonary disease;; Xifaxan ...Read more
-
James Clayton "Jim" Grahlman Obituary (2026) - Cedar Memorial Park Cemetery Funeral Home
In lieu of flowers, donations may be made in Jim's memory to the Iowa Chapter of Huntington's Disease Society of America at iowa.hdsa.org. Cedar ...Read more
-
Millions Of Us Could Develop Dementia In The Coming Years - IFLScience
Huntington's disease is ultimately a genetic disease, so we know what ... Huntington's disease. Up until now, diagnosis required you to start ...Read more
-
ClearPoint stock drops 23% after Huntington's treatment fails key trial milestone - Pluang
ClearPoint Neuro's stock fell 23.12% after its partner uniQure announced that a Huntington's disease treatment failed to meet a primary clinical ...Read more
-
MDS Congress 2026: Late-Breaking Data Snapshot | NeurologyLive
... Huntington disease and Tourette syndrome, with the key results that matter for practice ... Huntington's disease chorea: results from the 5-year ...Read more
-
Tips to ease my fear when thinking about future Huntington's symptoms
This banner image for the HD in Color column by Tanita Allen features illustrations of several. Living with Huntington's disease (HD) has changed the ...Read more
-
uniQure: The Market Graded The Wrong Exam (NASDAQ:QURE) | Seeking Alpha
Executive Summary. UniQure's one-time gene therapy AMT-130 for Huntington's disease, a debilitating neurodegenerative disease with no other therapies ...Read more
-
FDA's latest rare disease framework seeks to prioritize consistency in flexibility - BioSpace
... disease therapies to patients faster ... Huntington's disease gene therapy AMT-130. And the use of an externally ...Read more
-
Nuevocor Launches LMNA Cardiomyopathy Gene Therapy Trial - GenomeWeb
UniQure's Stock Falters on Latest Huntington's Disease Trial Data. Footer. About Us · Advertise · Subscribe · Contact Us · FAQ · Jobs · Reprints ...Read more
-
Mending the fabric of your genes - HDBuzz
Your Voice Matters: Using Speech to Monitor Huntington's Disease. October 8, 2026. Previous · HDBuzz. Huntington's disease research news. In plain ...Read more
-
LOI Modifier Linked to Neuron Loss in Huntington's Disease - DocWire News
CAG-CCG LOI Modifier Linked With Somatic Expansion and Loss of Medium Spiny Neurons in Huntington's Disease ... Loss-of-interruption variants in the CAG ...Read more
-
Transcripta Bio Announces Research Collaboration to Advance Discovery of New ALS Treatments
... Disorder (ASD), and Huntington's Disease (HD). The company is based in Palo Alto, California. For more information, visit transcriptabio.com ...Read more
GoogleNews-Aggregator
HDinHD > GoogleNews-Aggregator
